180 related articles for article (PubMed ID: 26287282)
1. Biomarker development, from bench to bedside.
Stenman UH
Crit Rev Clin Lab Sci; 2016; 53(2):69-86. PubMed ID: 26287282
[TBL] [Abstract][Full Text] [Related]
2. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
[TBL] [Abstract][Full Text] [Related]
3. Epitope analysis and detection of human chorionic gonadotropin (hCG) variants by monoclonal antibodies and mass spectrometry.
Lund H; Paus E; Berger P; Stenman UH; Torcellini T; Halvorsen TG; Reubsaet L
Tumour Biol; 2014 Feb; 35(2):1013-22. PubMed ID: 24014048
[TBL] [Abstract][Full Text] [Related]
4. Standardization of Epitopes for Human Chorionic Gonadotropin (hCG) Immunoassays.
Berger P; Lapthorn AJ
Curr Med Chem; 2016; 23(30):3481-3494. PubMed ID: 27237818
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
Kasurinen A; Laitinen A; Kokkola A; Stenman UH; Böckelman C; Haglund C
Acta Oncol; 2020 Jun; 59(6):681-688. PubMed ID: 32124669
[No Abstract] [Full Text] [Related]
6. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
[TBL] [Abstract][Full Text] [Related]
7. Enzyme Immunoassay of Urinary β-Core Fragment of Human Chorionic Gonadotropin as a Tumor Marker for Ovarian Cancer.
Nishimura R; Koizumi T; Das H; Takemori M; Hasegawa K
Methods Mol Med; 2001; 39():135-41. PubMed ID: 21340764
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.
Lyytinen I; Lempinen M; Nordin A; Mäkisalo H; Stenman UH; Isoniemi H
Scand J Gastroenterol; 2013 Sep; 48(9):1066-73. PubMed ID: 23889187
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites.
Birken S; Berger P; Bidart JM; Weber M; Bristow A; Norman R; Sturgeon C; Stenman UH
Clin Chem; 2003 Jan; 49(1):144-54. PubMed ID: 12507971
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
[TBL] [Abstract][Full Text] [Related]
11. TATI as a biomarker.
Itkonen O; Stenman UH
Clin Chim Acta; 2014 Apr; 431():260-9. PubMed ID: 24583226
[TBL] [Abstract][Full Text] [Related]
12. Dramatic increase in serum trypsinogens, SPINK1 and hCGβ in aortic surgery patients after hypothermic circulatory arrest.
Stewart JA; Koistinen R; Lempiäinen A; Hotakainen K; Salminen US; Vakkuri A; Wennervirta J; Stenman UH; Koistinen H
Scand J Clin Lab Invest; 2020 Dec; 80(8):640-643. PubMed ID: 32967482
[TBL] [Abstract][Full Text] [Related]
13. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
Stenman UH
Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
Koskensalo S; Hagström J; Louhimo J; Stenman UH; Haglund C
Oncology; 2012; 82(4):234-41. PubMed ID: 22508321
[TBL] [Abstract][Full Text] [Related]
17. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum.
Kardana A; Cole LA
J Clin Endocrinol Metab; 1994 Sep; 79(3):761-7. PubMed ID: 7521352
[TBL] [Abstract][Full Text] [Related]
19. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin.
Bristow A; Berger P; Bidart JM; Birken S; Norman R; Stenman UH; Sturgeon C;
Clin Chem; 2005 Jan; 51(1):177-82. PubMed ID: 15514095
[TBL] [Abstract][Full Text] [Related]
20. TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
Björkman K; Kaprio T; Beilmann-Lehtonen I; Stenman UH; Böckelman C; Haglund C
Oncology; 2022; 100(1):22-30. PubMed ID: 34794144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
